that acts on two types of cholinergic receptors: nicotinic and muscarinic receptors (Pappano 2007) . The cholinergic anti-inflammatory pathway is a mechanism whereby local inflammation is modulated by the brain via the vagus nerve and nAChRs. α-7-nAChR, a ligand-gated ion channel, mediates the antiinflammatory effects of cholinergic stimulation (Yeboah et al. 2008) . The Janus kinase (JAK) family of cytosolic tyrosine kinases, traditionally thought to be coupled to cytokine receptors such as those for the erythropoietin and interleukins, has four members (JAK1, JAK2, JAK3 and TYK2) (Chen et al. 2012 ). Once activated, JAKs tyrosine phosphorylate and activate other signaling molecules, including the STAT family of nuclear transcription factors after binding of STATs to the receptor (Becerra-Díaz et al. 2011) . It is evident that both JAK2 and STAT3 play a pivotal role in anti-apoptotic signaling in the field of myocardial injury (Barry et al. 2007 ). In addition, it has been demonstrated that Nrf-2, a redox sensitive transcription factor, plays a crucial role in maintaining cell survival mechanisms (Dinkova-Kostova and Abramov 2015) . Under oxidative and inflammatory stress, Nrf-2 translocates from cytoplasm to nucleus and promotes expression of downstream cytoprotective enzymes, such as hemeoxygenase-1(HO-1), NADPH quinone oxidoreductase-1 (NQO-1) and thioredoxin reductase-1 (TRXR-1) that attenuate tissue injury (Loboda et al. 2016 ).
Erythropoietin (EPO) is a hypoxia-inducible hematopoietic factor, a key protein in erythrocyte production, which is predominantly expressed in the kidney. EPO has multiple protective effects, including antioxidant, anti-inflammatory, angiogenic, and anti-apoptotic effects (Genc et al. 2004) . A previous study from Witthuhn et al. demonstrated that EPO could induce tyrosine phosphorylation of JAK2 kinase in vitro (Witthuhn et al. 1993) . There is vast and proved evidence that erythropoietin receptor (EPOR) is expressed in non-hematopoietic tissues (Arcasoy 2010) , such as liver and spleen (David et al. 2005; Gammella et al. 2015) . Therefore, the present investigation was conducted to test whether EPO could mitigate the deleterious response elicited by TBI associated MOD and ARS with special emphasis liver and spleen as highly radiosensitive vital organs. Moreover, the implication of α-7-nAChR-JAK-2/STAT-3-Nrf-2 signaling cascade in the cytoprotective efficacy of EPO against ARS. D r a f t D r a f t
Experimental design and treatment protocol
Eighty rats were randomly categorized into four groups as follows: Group I (control group; C) were normal rats that were intraperitoneally (i.p.) administered the vehicle at corresponding volumes (serum albumin 2.5 mg/ml in isotonic saline solution 0.9%; 2 ml/Kg) at corresponding times; Group II (irradiated group; R) were the rats to which we administered the vehicle at the corresponding volume (serum albumin 2.5 mg/ml in isotonic saline solution 0.9%; total volume of 2 ml/Kg body mass) 24 hours post irradiation with sublethal TBI 7 Gy (Venkateswaran et al. 2016) at the 1 st day of experimental course; Group III (erythropoietin group; EPO) were rats received a single i.p. injection at a dose of (5000 IU/Kg body mass; i.p.) of EPO (Elshiekh et al. 2015) reconstituted in 2 ml/Kg body mass of vehicle, Group IV (irradiated erythropoietin treated; EPO+ R) were rats exposed to sublethal irradiation (7 Gy) and received EPO at 24 hours post irradiation. Animals were observed and monitored for 30 days for radiation sickness symptoms and mortality recording, these data were expressed as percentage of survival and body weights were recorded weekly along 4 weeks at specific time points.
At the end of the experimental period (30 days), the survived rats were sacrificed under gentle diethyl ether anesthesia prior to blood, liver and spleen collection. Liver and spleen were dissected out and weighed to calculate liver and spleen weights to body weight ratios.
Survival analysis and radiation sickness
To determine the radiomitigative effect of EPO against sublethal TBI, the survival rate of rats for 30 days was investigated and data were expressed as survival percentage (Jothy et al. 2016) . Mortalities time points were recorded and animals were thoroughly observed for clinical visual observations included signs of illness, epilation, alterations in skin and fur, irritability and behavioral patterns.
D r a f t
Swelab alpha auto hematological counter according to the method of Dacie and Lewis (2001) . Blood smears were prepared as soon as possible after blood collection on glass slide and quickly dried and stained with Leishman's stain for differential blood count.
Tissue collection and preparation
For the different biochemical measurements, blood samples were collected and allowed to stand for 30 min at 37 °C, and then centrifuged at 3000g for 15 min at 4 °C to separate sera, and then were stored at -70 °C for the determination of hepatotoxicity parameters such as the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), glutamate dehydrogenase (GLDH) as a prominent marker of hepatic injury (Jaeschke and McGill 2013) and caspase-cleaved cytokeratin-18 M30 (CK-18 M30) which is an epithelial cell-specific filament released into circulation during cell death, an outstanding marker of hepatic apoptosis (Wei et al. 2017) . Also, interleukin-10 (IL-10) was estimated in serum as an indicator for splenic function (Hassan et al. 2014) . The liver and spleen tissues were quickly harvested, and one part of the liver and spleen tissues was instantly fixed in 10%
phosphate-buffered formaldehyde for histological examination. The remaining portion of the excised hepatic lobe and spleen was divided into 2 separate pieces for different biochemical assessments. To this end, the first part was homogenized in 10 volumes of ice-cold phosphate buffer (100 mmol·L -1 , pH 7.4) to determine oxidative stress markers (malondialdehyde; MDA and nitric oxide; NOx) and the cellular proliferation marker (arginase activity). The second portion of the liver and spleen was subdivided into 2 equal portions: for reverse transcription PCR analysis, the first portion of hepatic lobules (250 mg) and spleen were homogenized in lysis buffer (200 mmol·L -1 NaCl, 5 mmol·L 
Serum biochemical tests
The collected sera were used for the colorimetric estimation of AST and ALT as previously described (Reitman and Frankel 1957) , by measuring the amount of pyruvate or oxaloacetate produced by forming 2, 4-dinitrophenylhydrazone. The color produced was measured spectrophotometerically at 546 nm using the commercial kits purchased from Biodiagnostic (Dokki, Giza, Egypt). Serum levels of GLDH and CK-18 M30 were measured using a corresponding commercial immunoassay of rat GLDH ELISA kit (Elabscience, USA) and rat CK-18 ELISA kit (MyBiosource, San Diego, CA, USA)
according to the manufacturers' instructions. GLDH and CK-18 M30 were expressed as µIU/ml and mIU/ml, respectively. Serum IL-10 level was determined using a commercial rat IL-10 ELISA kit (Quantikine, R&D systems, Minneapolis, Minnesota, USA) according to the manufacturers'
instructions. IL-10 levels are expressed in pg/ml.
Liver and spleen tissue biochemical measurements
In liver and spleen tissues' homogenates, thiobarbituric acid reactive substances (TBARS), represented by MDA as an index for lipid peroxidation, were used to determine oxidative damage, following the method of Lefevre et al. (1998) . Briefly, 0.8% TBA (1.5 ml), 8.1% SDS (200 µl), 20% acetic acid (1.5 ml) and distilled water (600 µl) were added to 200 µl tissue homogenate at temperature of 95°C for 30 min and immediately cooled on ice to form colored product. The resultant pink color was a representative of TBARS and was measured colorimetrically at 534 nm using a spectrophotometer. In addition, hepatic and splenic NO levels were estimated indirectly as nitrite/nitrate concentrations according to the method of Miranda et al. (2001) , where vanadium trichloride was used to reduce nitrate into nitrite. The pink azo-dye produced by the reaction of nitrite with sulfanilic acid, followed D r a f t eliminated with a DNase-on-column treatment, which was supplied with the kit. The RNA concentration was determine spectrophotometrically at 260 nm using the NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Waltham, Mass.), and RNA purity was checked by means of the absorbance ratio at 260/280 nm. RNA (1 µg) was used in the subsequent cDNA synthesis reaction, which was performed using the Reverse Transcription System (Promega, Leiden, the Netherlands Amersham detection kit, according to the manufacturer's protocols, and exposed to X-ray film. Protein levels were quantified by densitometric analysis of the auto-radiograms using a scanning laser densitometer (Biomed Instruments). Results were determined after normalization for β-actin protein expression (as the housekeeping protein) (Mingone et al. 2003) .
Histopathological examination
Autopsy samples from the livers and spleens of the rats in different groups were harvested and fixed in 10% formol saline for 24 h. The samples were washed with tap water, and then serial dilutions of alcohol (methyl, ethyl, and absolute ethyl) were used for dehydration. The specimens were cleared in xylene and embedded in paraffin at 56 °C in a hot-air oven for 24 h. Paraffin-bees wax tissue blocks were prepared for sectioning at a thickness of 4 µm using a slide microtome. The tissue sections were then collected onto glass slides, de-paraffinized, and stained with hematoxylin and eosin (H&E). The preparations obtained were visualized using a Nikon microscope at a magnification of ×400 (Banchroft et al. 1996) .
Statistical analysis
The data are the mean ± SEM. Statistical analysis was done using one-way analysis of variance (ANOVA), followed by a Tukey-Kramer post-hoc multiple comparisons test among treatment means.
Survival studies' data were analyzed using the Kaplan-Meier method followed by Mantel-Cox (logrank) and Gehan-Breslow-Wilcoxon tests for assessment of significant differences. Values for P < 0.05 were considered statistically significant. All analyses were estimated using SPSS software, version 21.
Based on sample size calculation by ANOVA, experimental design allows detecting the difference between groups ranging from 35-40% with a SD 25% of mean and power (β) required to detect a difference of a similar magnitude to that observed at 30 days (observed effect size of 1.2 for single sublethal 7 Gy) was estimated by a post hoc power calculation with the lowest sample size (N=20/ group) has a β = 0.8 to detect an effect of 1 with an error α = 0.05. The vehicle-treated irradiated rats (R group) exhibited typical signs of radiation sickness such as reduced food and water intake, mild local skin reactions including dermal erythma and depilation, irritability followed by lethargy, ruffling of hair, emaciation, diarrhea accompanied by tarry stool and facial edema were observed 3 days post-irradiation. Survival analysis showed a significant difference (P< 0.0001) in survival time among groups. In addition, Kaplan-meier survival plot indicated that the first death event has occurred on day 5 with a median survival rate on day 20 following irradiation in R group (Fig 1 A) . Moreover, R group showed only 30% (6 out of 20 rats) survival on the last day of survival analysis (day 30) (Fig 1 A) . On the other hand, EPO+R had reduced signs of radiation sickness and extended survival rates by 35% over the vehicle-treated R group with the overall survival rates of 65% (13 out of 20 rats) at the end of the survival analysis (Fig 1 A) . Notably, EPO+R delayed the onset of radiation-induced mortality to be recorded on day 13 (Fig 1 A) as compared to R group, suggesting the prolonged survival rates and confirming the radiomitigative efficacy of EPO. The Mantel-Cox (log rank) and Gehan-Breslow-Wilcoxon statistics indicated that the survival curves were significantly different (P< 0.0001) among treated groups. All animals in control and EPO groups were survived until the end of experimental period with 100% survival rates (Fig 1 B) and displayed no signs of toxicity during the survival test. 
Effect of EPO post-exposure treatment on body weight changes and organ indices after TBI
Total body weight was measured at the beginning and the end of the experimental course (Fig 2 A) .
Results in Fig 2A&B indicated no significant change in mean body weight between control and EPOtreated normal rats. The percent change in body weight between the initial and final weights showed a significant decline (P< 0.05) as shown in R group when compared to the corresponding control (Fig 2   B ). In R group, the body weight loss started at the first week post-irradiation and continued till it reach the maximum body weight loss percentage at the 4 th week after TBI and recorded 8.23 and 23% weight loss at the 1 st and 4 th weeks, respectively (Fig 2 B) . On the other hand, EPO+ R reduced the body weight loss and substantially ameliorated (P< 0.05) the percent change in body weight compared to R sole treatment (Fig 2 A& B) . The ratio between the liver weights to the total body weight revealed a significant increase (P< 0.05) in R group compared to the control set and exhibited 161.1 % change in D r a f t the liver weight (Fig 2 C) . Contrariwise, the ratio of spleen weight to the total body weight exhibited a remarkable reduction (P< 0.05) in R group as compared to the control set with a percent change of 47.2 (Fig 2 D) . Upon EPO post-exposure administration to irradiated rats (EPO+ R), the radiation-induced alterations in the organ indices were significantly reversed (P< 0.05) as depicted in Fig 2 C&D .
Whereas, there were no significant changes in liver and spleen weights in EPO treated non-irradiated rats when compared to their respective controls (Fig 2 C&D) . EPO post-exposure treatment augmented BM and spleen cellularity after TBI Bone marrow (BM) and spleen are the most radiosensitive hematopoietic and lymphoid organs. To evaluate the radiomitigative potential of EPO sub-lethal TBI, BM and spleenocytes viability were assessed. Exposure of rats to sub-lethal TBI resulted in a significant decrease (P< 0.05) in BM and spleenocytes viability when compared to control rats (Fig 3) . However, accelerated BM and spleenocytes reconstitution was observed in EPO+ R group showing significant elevation (P< 0.05) above the R group (Fig 3) . Worthwhile, no significant change was recorded in EPO group when compared to the control set. D r a f t
Impact of EPO post-exposure treatment on leukocyte differential of irradiated rats
Administration of EPO to normal non-irradiated rats resulted in non-significant change in leukocyte differential when compared to control rats. Exposure of rats to TBI single sub-lethal fraction at 7 Gy markedly diminished (P< 0.05) lymphocytes, monocytes, neutrophils, and eosinophils percentage at 3 rd and 7 th days post-irradiation and continued until the last day of the experimental period (30 th day) in R group as compared to control (Fig 5) . In EPO+ R group, EPO treatment significantly restored (P< 0.05) lymphocytes percentage and normalized monocytes, neutrophils and eosinophils percentages to reach nearly the control values as compared to R group rats (Fig 5) . This recovery in leukocyte population in EPO+ R group indicates that EPO counteracts radiation-induced myelosuppression. EPO post-exposure treatment improved hepatotoxicity profile of irradiated rats Figure 6 depicted no significant change in the hepatotoxicity biomarkers (AST, ALT, GLDH, and CK-18 M30) in EPO group as compared to control (Fig 6 A-C) . On the other hand, irradiation of rats induced a significant increase (P< 0.05) in serum AST, ALT activities (Fig 6 A) as well as GLDH and CK-18 M30 levels (Fig 6 B& C) when compared to the control set. Whereas, EPO+ R group revealed a marked amelioration (P< 0.05) in the aforementioned parameters as compared to R group (Fig 6 A-C) .
Moreover, liver sections from the control and EPO group showed that normal architecture of the hepatic lobule was preserved (Fig 6 D ; C& EPO). On the other hand, total body irradiation of rats (7 Gy) caused a sever histological degeneration in the hepatic architecture as represented by sever dilatation and congestion in the portal vein as observed in the portal area associated with multiple numbers of newly formed bile ductules as well as periductal fibrosis while the parenchyma showed degenerative change in the hepatocytes ( and p-STAT-3 protein expression as well as Nrf-2 and HO-1 mRNA levels in hepatic and splenic tissues as revealed in R group when compared to EPO group and control animals (Fig 7 A-G& Fig 8) .
Interestingly, EPO+ R significantly enhanced (P< 0.05) α-7-nAChR, p-JAK-2, and p-STAT-3 hepatic and splenic protein expression when compared to R group (Fig 7 A-G) . Consequently, hepatic and splenic Nrf-2 and HO-1 mRNA levels showed a significant elevation (P< 0.05) in EPO+ R group as compared to R group set (Fig 8) , suggesting the stimulation of hepatic and splenic JAK-2/STAT-3/Nrf-2/HO-1 signaling axis mediated via α-7-nAChR stimulation following EPO post-exposure treatment in irradiated rats. To further elaborate the reason that EPO administered at 24 hours post-irradiation afforded hepatic and splenic protection against radiation-induced oxidative damage, we next explored the underlying mechanism. Hence, we assumed that EPO might activate Nrf-2-antioxidant responsive elements (ARE). Next, we evaluated the expression of ARE-mediated genes (NQO-1 and TRXR-1) to determine whether EPO could regulate the endogenous antioxidant system in liver and spleen of TBI rats. Fig 9 showed that administration of EPO to non-irradiated rats significantly enhanced (P< 0.05) D r a f t NQO-1 and TRXR-1 gene expression and recorded 3.6 and 3.2 fold changes in the liver tissue, respectively and 2.7 and 2.5 fold changes in the spleen tissue, respectively when compared to the respective control (Fig 9 A) . Expectedly, irradiation of rats (R group) resulted in a substantial reduction (P< 0.05) in NQO-1 and TRXR-1 expression by 55 and 64 %, respectively in the liver tissue as well as 53 and 66 %, respectively in the spleen as compared to the control group (Fig 9 A) . However, a remarkable elevation (P< 0.05) was observed in MDA and NO levels (Fig 9 B&C) paralleled by a significant reduction (P< 0.05) in arginase activity and IL-10 serum level (Fig 9 D&E) in R group as compared to the control set. Contrariwise, EPO+ R significantly upregulated (P< 0.05) NQO-1 and TRXR-1 gene expression by 6.4 and 7.3 fold changes, respectively in the hepatic tissue as well as a fold changes of 4.6 and 6.5, respectively in the splenic tissue when compared to R group (Fig 9 A) .
Moreover, MDA and NO levels were significantly diminished (P< 0.05) accompanied by a significant rise (P< 0.05) in arginase activity and IL-10 level were noted in EPO+ R group as compared to R group (Fig 9 B-E) , suggesting the restoration of redox balance through the upregulation of phase II antioxidant enzymes expression and arginase activity. In the same line, EPO post exposure treatment (EPO+ R) improved splenic histological architecture and restored spleenocytes and splenic cellular matrix against splenic depopulation induced by R (Fig 9 F) . EPO post-exposure treatment downregulates pro-apoptotic genes (Bax and p53) with restoration of anti-apoptotic Bcl-2 expression in liver and spleen of TBI rats
Total body irradiation of rats instigated apoptosis in liver and spleen as indicated by a 3.4 and 3.7 fold increase in Bax mRNA expression, respectively paralleled by a 2.7 and 3.2 fold elevation, respectively in caspase-3 activity, as a reliable apoptotic marker (Fig 10 A& C) . However, hepatic p53 mRNA expression showed non-significant change between all groups and revealed a pronounced rise (P< 0.05) in splenic p53 expression in R group as compared to control rats (Fig 10 A) . On contrary, the antiapoptotic Bcl-2 mRNA levels were significantly diminished (P< 0.05) in hepatic and splenic tissues of untreated irradiated animals as compared to normal rats (Fig 10 A) . Surprisingly, EPO post-exposure treatment of irradiated rats as in EPO+ R group counteracted these changes in favor of cell survival (Fig 10 A-C) . Moreover, EPO+ R recovered the balance between the pro-apoptotic Bax expression and the anti-apoptotic Bcl-2 expression as indicated by Bax/Bcl-2 ratio when compared to untreated irradiated rats (Fig 10B) , denoting suppression of apoptosis as a crucial event in the radiomitigative potential of EPO. D r a f t
Discussion
Although the search for suitable, safe and effective radiation countermeasures was initiated more than half a century ago, it still represents a global challenge (Hofer et al. 2017) . Remedies for the accidental exposure of individuals, as well as mass populations, to high doses of ionizing radiation are scarce (Gaberman et al. 2013) . Radioprotectors are compounds that protect against radiation injury when given prior to radiation exposure. Whereas, radiomitigators can protect against radiation injury when given after exposure but before symptoms appear. Radioprotectors and radiomitigators can potentially improve the outcomes of radiotherapy for cancer therapy by allowing higher doses of radiation and/or reduced damage to normal tissues (Rosen et al. 2015) . Preliminary studies of radioprotectors and mitigators typically involve investigation of the acute effects of TBI in rodents, using survival as the end-point. While TBI affects multiple organ systems, death in humans and rodents in the first 30 days is mainly due to two mechanisms: (1) The current investigation highlights, for the first time, the radiomitigative action of EPO against ARS using TBI rodent model. EPO is a well known glycoprotein cytokine and hematopoietic growth factor, which plays a pivotal role during later stages of erythroid maturation as well as proliferation, differentiation and survival of primitive hematopoietic stem and progenitor cells (Singh et al. 2014 ).
Herein, we attempted to explore the potential effect of EPO on 30 days survival, BM and spleen cellularity, BM reconstitution and peripheral hematopoietic profile in sublethally irradiated rats. In addition, our study provides insight into the probable molecular mechanisms behind the radiomitigative effect of EPO in TBI model. In this study, a better understanding of the molecular targets might be involved in MOD that complicates ARS gives rise to novel strategies to counteract ARS and improves outcomes.
D r a f t
In the present investigation, R-group exhibited typical signs of radiation sickness with median survival rate of day 20 and 70% mortality at day 30 of the survival analysis following TBI (Fig 1A&B) . These results are in agreement with previous reports (Kaushik et al. 2012; Deng et al. 2015; Wang et al. 2015; Sato et al. 2015) . Ionizing radiation can cause injury to GI and hematopoietic systems leading to defective hematopoiesis according to radiation dose, dose rate and radiation quality (Gridley et al.
2001
; Ghosh et al. 2012; Soliman et al. 2015) . This is followed by thrombocytopenia and concomitant hemorrhages beside effects in adaptive immune system resulting from deficient lymphopoiesis and apoptosis of lymphocytes (Wilkins et al. 2002) . Sepsis is the primary cause of mortality during the early phase of the radiation-induced hematopoietic syndrome. Low levels of circulating immune blood cells and increased translocation of bacteria from the gastrointestinal tract into circulation and other tissues can lead to opportunistic infections and sepsis (Mauch et al. 1995; Ghosh et al. 2012) . In R group, a significant reduction in body weight gain starting from the 1 st week post irradiation and continues till the 4 th week of the experimental course as compared to control and EPO+ R groups as shown in Fig 2A&B. These changes of body weight gain were coupled with a significant increase in liver mass index and marked decline in splenic index when compared to control and EPO+ R groups (Fig 2B&C) . Similar reductions in body mass caused by irradiation have been well-documented (Moccia et al. 2010; El Shawi et al. 2015; Hasan et al. 2017) . Weight reduction observed after irradiation of animals denotes severe toxicity, which might occur through biphasic changes. In the first phase, weight loss might due to gastrointestinal damage following irradiation, whereas the second phase of weight loss is associated with decreased water intake and increased rates of catabolic processes (Nakamura et al. 1968) . Moreover, the increase in the liver mass index (%) of R group when compared to control and EPO+ R groups is suggestive of progressive hepatic damage and liver swelling in the irradiated rats. Our results are in agreement with previous studies (Pradeep et al. 2008; El Shawi et al. 2015) . Consistently with previous findings (Jothy et al. 2016; Venkateswaran et al. 2016 ), we observed splenic atrophy after 30 days post irradiation with sublethal dose as revealed in Fig   2D . This might be due to multiple unrecoverable injuries and splenic depopulation induced by radiation (Bala and Kaur 2015) , which in turn, leads to spleenocytes apoptosis and cell cycle arrest (Ha et al. 2013 ).
Results of the present study, clearly demonstrated the ability of EPO to mitigate acute radiation lethality as revealed by prolonged survival of EPO+ R group compared to R group (Fig 1A&B) . Also, EPO post-exposure treatment 24 hrs following TBI recovered the body weight gain along the experimental time course (Fig 2A&B) , restored organ indices of liver and spleen with the remarkable D r a f t absence of splenic atrophy (Fig 2 C&D) and accelerated BM and spleen reconstitution and cellularity (Fig 3) . Moreover, the ability of EPO post-exposure treatment to expedite recovery of the hematopoietic system seen here suggests that it is able to stimulate the proliferation and differentiation of spared stem cells in a regulated manner thereby; repopulating the blood compartments and the BM through hematopoiesis, mitigating TBI-induced lethality in rats (Fig 4& 5) . In this study, we observed a significant decrease in all hematological parameters and leukocytes differential in the blood at days 3, 7, 15 and 30 after TBI in R group compared to control, suggesting the impaired hematopoiesis and myelosuppression. Proliferation of stromal cells and bone-marrow stromal layer formation are sensitive to radiation in vitro, while established bone-marrow stromal layer is relatively resistant to radiation (Zhang et al. 2010) . Since the BM is a primary target for irradiation, the recovery was dependent on extramedullary cell division in the thymus and spleen (Abu-Sinna et al. 2005) . TBI causes considerable decrease in the hematological values like erythrocytes, leukocytes and lymphocytes (Ashry et al. 2009; Soliman et al. 2015) . Decrease in the number of erythrocytes in the present study was imputed to depletion of erythroblast differentiation and reticulocyte release from the BM and the loss of cells from the circulation by hemorrhage (Nunia et al. 2007 ). Moreover, depletion of lymphocytes in R group is attributed to radiation induced apoptosis and necrotic cell death (Zarybnicka et al. 2013 ). Leukocytes and lymphoid organs are also highly sensitive to radiation and oxidative stress (Soliman et al. 2015) . Radiation does not only affect cell growth, proliferation, and viability as well as migration capacity of stem cells but also acts as a promoter of apoptosis (Ma et al. 2010 ). In individuals exposed to high doses of radiation, both mature lymphocytes and BM stem cells were severely damaged, causing profound depletion of granulocytes and natural killer cells, which together defend against microbial invasion, causing death from active infections (Wilkins et al. 2002) .
These previous investigations may explain the significant decline in both BM and spleen cellularity (Fig 3) .
Expectedly, EPO post-exposure treatment exhibited a significant acceleration in RBCs and WBCs count restoration coupled with major recovery in Hb and PLT content as well as leukocytes differential as compared to R group (Fig 4&5) . This could be interpreted in the view that EPO enhance survival of erythroid progenitors cells through reducing their apoptosis via interaction with its receptor (EPO-R) expressed on them (Chateauvieux et al. 2011 ). EPO acts primarily on colony forming unit erythroid (CFU-E) inducing the proliferation and maturation through the stages of proerythroblast followed by reticulocytes and finally mature erythrocytes (Hillman and Henderson 1969; Singh et al. 2014 ).
However, it acts synergistically with other growth factors to regulate the maturation and proliferation D r a f t of erythroid cell development (Douay et al. 2009 ). This synergism stimulates pluripotent stem cell to differentiate into the CFU granulocyte, erythroid, monocyte, megakaryocyte (GEMM), and the myeloid stem cell. The CFU-GEMM then differentiates into the specific CFU for erythroid, granulocytes, monocytes, macrophages, eosinophils, and megakaryocytes cell precursors (Smith 1990 ). Under sublethal radiation stress, which is characterized by specific injury to the extravascular erythron, initial expansion and maturation of EPO-responsive erythroid progenitors exclusively in the BM, and subsequent reseeding of extramedullary sites, as spleen (Peslak et al. 2012) . Coinciding with this notion, Kato et al. (1999) reported that EPO stimulates migration of BFU-E and CFU-E from BM to spleen. These effects might account for restored BM and spleen cellularity upon EPO treatment in irradiated rats.
Beside hematopoietic syndrome as a landmark event in ARS, exposure to high-dose radiation induces long-term damage in visceral organs such as highly radiosensitive liver and spleen. These delayed Hence, we focused our study on the implication of α-7-nAChR-JAK-2/STAT-3 axis and subsequent redox sensitive Nrf-2/HO-1 signaling in ARS and MODS in irradiated rats and possible radiomitigative effect of EPO.
Strikingly, our findings revealed a profound downregulation in hepatic and splenic protein expression of JAK-2, p-JAK-2, STAT-3, p-STAT-3 with increased JAK-2/STAT-3 to p-JAK-2/p-STAT-3 ratio as well as a significant reduction in hepatic and splenic α-7-nAChR protein expression (Fig 7A-G) , concomitantly with significant suppression in Nrf-2 gene expression and its molecular targets HO-1 (Fig 8) , NQO-1 and TRXR gene expression (Fig 9A) 30 days after TBI in R group as compared to the control set. Ionizing radiation inflicted cellular injuries are primarily attributed to deleterious effect of free radicals and ROS generation (Srivastava et al. 2014) . Irradiation induced ROS generation is a result of imbalance between production of free radicals and antioxidant defense mechanisms and is characterized by an increase in ROS and MDA as well as decrease in the antioxidant machinery (Zhu et al. 2007 ). Indeed, our findings implied a significant rise in oxidative stress markers (MDA and NO) levels in liver and spleen 30 days post irradiation in R group compared to control group (Fig 9B&   C) .This is in line with findings were obtained by Marina et al. (2015) and Zhou et al. (2017) . Nrf2 is a transcription factor and a cellular sensor of oxidative stress (Pan et al. 2016) . Moreover, Nrf2 is found to promote the survival of irradiated cells, including BM cells, through ROS scavenging (Sekhar and
Interestingly, EPO post exposure treatment of irradiated rats (EPO+ R) markedly upregulated JAK-2, p-JAK-2, STAT-3, p-STAT-3 with increased p-JAK-2/p-STAT-3 to JAK-2/STAT-3 ratio, suggesting activation of JAK-2/STAT-3 signaling and boosted expression of the cholinergic anti-inflammatory α-7-nAChR in liver and spleen compared to R group (Fig 7A-G) . Furthermore, EPO post exposure treatment restored redox balance via reducing oxidative stress markers (MDA and NO) and enhancing expression of redox regulator genes (Nrf-2, HO-1, NQO-1 and TRXR-1) in hepatic and splenic tissues versus R group. In non-eryhtroid tissues, EPO acts principally through JAK-2/STAT-3 activation (Alnaeeli et al. 2014) . A plausible mechanism by which EPO modulates α-7-nAChR expression is through upregulation of unphosphorylated STAT-3 expression (Peña et al. 2010) . Therefore, EPO might act as positive allosteric modulator for α-7-nAChR. Moreover, EPO promoted expression of Nrf-2 and its downstream targets (HO-1, NQO-1 and TRXR-1), which played both antioxidant and antiinflammatory roles in liver and spleen of TBI rats. This antioxidant potential of EPO has been well documented (Osikov et al. 2015) . Worthwhile, EPO post exposure treatment recovered arginase activity that was inhibited by radiation ( Fig 9D) . Induction of iNOS expression and a marked generation of NO characterize an early-phase of radiation response, and increased generation of ornithine and its metabolism to polyamines are important elements of the repair-phase response to the injury (Shukla et al. 2009 ). Arginase-mediated conversion of arginine to ornithine is the initial step in polyamine synthesis and plays an important role in cellular proliferation (Tong and Barbul 2004) . Since polyamines are involved in the tissue regeneration, this shift in the L-arginine pathway toward ornithine production is very favorable for the host recovery from radiation injury. Arginase function is central to regulating overall arginine availability and cross-regulating the expression of iNOS production (Shukla et al. 2009 ). This could be reflected on decreased NO level in liver and spleen ( Fig   9C) concurrently with increased serum level of anti-inflammatory cytokine IL-10 (Fig 9E) , which is produced in large amount from activated B-lymphocytes in spleen (Gotoh et al. 2012 ). IL-10 has been shown to slow down progression of apoptosis in immune-derived cells and decreased serum level implies splenic hypo-function and atrophy (Hassan et al. 2014) . Accordingly, EPO treatment in irradiated rats significantly reduced expression of the pro-apoptotic genes (Bax and p53) and upregulated expression of anti-apoptotic genes (Bcl-2) as well as obviously diminished Bax/Bcl-2 ratio in hepatic and splenic tissues paralleled by diminished caspase-3 activity in both tissues (Fig 10) ;
however, no significant change was recorded in hepatic p53 mRNA expression, since liver and spleen show variable degree of radiosensitivity (Komarova et al. 2000) . Thus, EPO treatment prevented apoptosis and favored survival of hepatic and splenic tissues against insults induced by radiation. Chen, J.K., Li, Z.P., Liu, Y.Z., Zhao, T., Zhao, X.B., Ni, M., et al. 2014 . Activation of alpha 7 nicotinic acetylcholine receptor protects mice from radiation-induced intestinal injury and mortality. Radiat. Res. 
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